Aethlon Medical Inc expected to post a loss of 78 cents a share - Earnings Preview

Aethlon Medical

11/08/2026 22:23

Aethlon Medical Inc AEMD.OQ AEMD.O is expected to  show no change in quarterly revenue when it reports  results on August 13 for the period ending June 30 2026

​LSEG's mean analyst estimate for Aethlon Medical Inc is for a loss of 78 cents per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Aethlon Medical Inc is $10.00, about 224.7% above its last closing price of $3.08
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-2.16
-2.01
-1.49
Beat
25.9
Dec. 31 2026
-2.38
-2.42
-2.45
Missed
-1.2
Sep. 30 2025
-3.50
-3.66
-3.74
Missed
-2.1​
Jun. 30 2025
-8.70
-8.60
-8.50
Beat
1.2
​​Mar. 31 2025
-9.80
-10.10
-79.70
Missed
-689.1
Dec. 31 2024
-16.80
-17.07
-10.40
Beat
39.1​
Sep. 30 2024
-16.00
-15.60
-16.00
Missed
-2.6
Jun. 30 2024
-24.47
-25.20
-27.20
Missed
-7.9
This summary was machine generated August 11 at 21:23 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)